منابع مشابه
Incentives for mitigation investment and more effective risk management: the need for public-private partnerships.
A key question facing both well-developed industrial countries and emerging economies is how to reduce future disaster losses while still providing financial protection to victims from these events. This paper proposes a strategy for the use of cost-effective risk mitigation measures coupled with insurance and/or new capital market instruments to achieve these objectives. The mix of these measu...
متن کاملSecuring the Containerized Supply Chain: Analysis of Government Incentives for Private Investment
To mitigate the threat that terrorists smuggle weapons of mass destruction (WMD) into the US through maritime containers, the US Bureau of Customs and Border Protection (CBP) inspects containers upon entry to domestic ports. Inspection-driven congestion is costly, and CBP provides incentives to firms to improve security upstream in the supply chain, thereby reducing the inspection burden at US ...
متن کاملInsufficient Incentives for Investment in Electricity Generation
In theory, competitive electricity markets can provide incentives for efficient investment in generating capacity. We show that if consumers and investors are risk averse, investment is efficient only if investors in generating capacity can sign long-term contracts with consumers. Otherwise the uncovered price risk increases financing costs, reduces equilibrium investment levels, distorts techn...
متن کاملIncentives for Subjective Evaluations with Private Beliefs
The modern web critically depends on aggregation of information from self-interested agents, for example opinion polls, product ratings, or crowdsourcing. We consider a setting where multiple objects (questions, products, tasks) are evaluated by a group of agents. We first construct a minimal peer prediction mechanism that elicits honest evaluations from a homogeneous population of agents with ...
متن کاملPrivate versus social incentives for pharmaceutical innovation.
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a model with a population of patients who can be treated with drugs that are horizontally and vertically...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Intereconomics
سال: 1973
ISSN: 0020-5346,1613-964X
DOI: 10.1007/bf02927620